Friday, 23 Aug 2019

You are here

RheumNow Week in Review – 2 September 2016

Dr. Jack Cush reviews highlights from this week in RheumNow:

  1. Amgen releases results of 12 mo RCT of denosumab vs risedronate in steroid Rx pts - Prolia had twice increase in BMD https://t.co/Et8jj40Keg
  2. FDA adds "Boxed Warning" to opiates & benzodiazepines (n=389) listing sleepiness, respiratory depression, coma and death https://t.co/olfszGus6S
  3. In the Last 10 yrs in Ireland, hospitalizations and surgery for RA were cut half, MTX use tripled and TNFi prescriptions were up 4900%. https://t.co/KUVhvqxgsc https://t.co/lc46pEHKZ5
  4. Canadian data same as US; #RA hosp. cut in half while #Gout hospitalizations have doubled https://t.co/qVnEAvN538 https://t.co/KFOpKxEPd3
  5. RA Care costs unchanged from 1998 to 2006. Outpt increased, hosp. decreased, Drug cost higher, but fewer sick days https://t.co/G1UkMk5S56
  6. Drug retention rates are same between elderly and younger RA pts on TNFi. D/C for AE in old and efficacy in young. https://t.co/ZPXlXvVpTS
  7. Dr. Langford: VTE is increased risk with active GPA, MPA or EGPA. However no current evidence attesting to need for automatic anticoagulation.
  8. Bactrim prophylaxis against pneumocystis should be given to all AAV pts during induction while receiving CTX or RTX therapy
  9. Dr. Langford: Bactrim (TMP/SMX) may be used for isolated upper airway disease; never used alone for severe GPA disease (eg, glomerulonephritis)
  10. Dr. Langford: after remission (w/ CTX or RTX), RTX can be used for maintenance w/ low risk of relapse
  11. Dr Carol Langford Gr Rounds - ANCA levels do NOT correlate well with disease activity and should not be used to guide therapy
  12. Flares Portend Damage in Rheumatoid Arthritis - Time for a New Strategy?
  13. Cost of Osteoporosis Care in the USA 
  14. FDA Approves Updated Denosumab Warnings 
  15. Nailfold Capillaroscopy Excludes Scleroderma in Raynaud’s
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

RheumNow Podcast – Upadacitinib FDA Approved for RA (8.23.19)

Dr. Jack Cush reports on the news and journal reports from the past week on RheumNow.com, including: how your genetics may shape your microbiome; GERD as a risk factor for TMJ?; how can MDA-5+ dermatomyositis be any worse; new drug happenings; StillsNow.com; and more.

RheumNow Podcast – Antibiotics Increase RA Risk (8.16.19)

Dr. Jack Cush reports the news and important journal articles from the past week on RheumNow.com.

RheumNow Podcast – Tricked Up Lupus Criteria (8.9.19)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com, including new SLE criteria, ULT in gout and MSU reductions, IVIG in ANCA vasculitis and non-TNF biologics outperform the TNF inhibitors.

EULAR Recommendations on Large Vessel Vasculitis

Th European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) was originally published in 2009. Since then there have been new randomised clinical trials and cohort analyses leading to an update the original recommendations.

RheumNow Podcast – More Than a Spot of Tea (8.2.19)

Dr. Jack Cush reviews the journal articles and news reports from the past week on RheumNow.com: MMP-7 and Myositis-ILD; Post-surgical gout attacks; CV events and testosterone; and a Boxed warning for tofacitinib.